Form 8-K - Current report:
SEC Accession No. 0000926617-14-000067
Filing Date
2014-12-17
Accepted
2014-12-17 16:00:16
Documents
9
Period of Report
2014-12-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K c617-20141217x8k.htm 8-K 49996
2 EX-99.1 c617-20141217ex991384e13.htm EX-99.1 68686
3 EX-99.2 c617-20141217ex99225805d.htm EX-99.2 47015
4 EX-99.3 c617-20141217ex993ba8194.htm EX-99.3 11451
5 EX-99.4 c617-20141217ex99449c485.htm EX-99.4 17038
6 GRAPHIC c617-20141217ex991384e13g1.jpg GRAPHIC 3884
7 GRAPHIC c617-20141217ex99225805dg1.jpg GRAPHIC 3884
8 GRAPHIC c617-20141217ex993ba8194g1.jpg GRAPHIC 3884
9 GRAPHIC c617-20141217ex99449c485g1.jpg GRAPHIC 3884
  Complete submission text file 0000926617-14-000067.txt   217804
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
VERMILLION, INC. (Filer) CIK: 0000926617 (see all company filings)

EIN.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34810 | Film No.: 141292502
SIC: 2835 In Vitro & In Vivo Diagnostic Substances